CHESTER, N.J. June 30 /PRNewswire-FirstCall/ -- Adams Respiratory Therapeutics, Inc. today announced that it is included in the new NASDAQ Global Select Market. The NASDAQ Global Select Market has the highest initial listing standards of any exchange in the world based on financial and liquidity requirements. Prior to the change, the Company had been listed on the NASDAQ National Market.
Beginning July 3, NASDAQ-listed companies will be classified under three listing tiers: NASDAQ Global Select Market, NASDAQ Global Market and NASDAQ Capital Market. NASDAQ also plans to launch indexes based on these new tiers.
NASDAQ announced the new three tier listing classification in February 2006. All three market tiers will maintain rigorous listing and corporate governance standards. For additional information about the NASDAQ Global Select Market, please go to: http://www.nasdaq.com/GlobalSelect.
About Adams Respiratory Therapeutics, Inc.
Adams is a specialty pharmaceutical company focused on the late-stage development, commercialization and marketing of over-the-counter and prescription pharmaceuticals for the treatment of respiratory disorders.
Adams Respiratory Therapeutics, Inc.
CONTACT: Investor or Media, Janet M. Barth, +1-908-879-2428, for AdamsRespiratory Therapeutics, Inc.
